Fidelity Investments’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.46K Buy
2,883
+2,560
+793% +$4.12K ﹤0.01% 5154
2026
Q2
$630 Buy
323
+319
+7,975% +$650 ﹤0.01% 5291
2026
Q1
$10 Buy
4
+3
+300% +$7 ﹤0.01% 5377
2025
Q4
$2 Sell
1
-310
-100% -$734 ﹤0.01% 5403
2025
Q3
$948 Buy
311
+310
+31,000% +$967 ﹤0.01% 5025
2025
Q2
$3 Sell
1
-6
-86% -$14 ﹤0.01% 5302
2025
Q1
$11 Buy
7
+6
+600% +$11 ﹤0.01% 5246
2024
Q4
$1 Buy
+1
New +$1 ﹤0.01% 5514
2024
Q3
– Sell
-7
Closed -$7 – 5642
2024
Q2
$7 Buy
+7
New +$7 ﹤0.01% 5306
2023
Q1
– Sell
-1
Closed -$3 – 5427
2022
Q4
$3 Buy
+1
New +$4 ﹤0.01% 5308
2022
Q2
– Sell
-1
Closed -$6 – 5518
2022
Q1
$6 Buy
+1
New +$6 ﹤0.01% 5397
2021
Q4
– Sell
-6
Closed – – 4708
2021
Q3
$0 Buy
6
+5
+500% +$36 ﹤0.01% 4759
2021
Q2
$0 Hold
1
– – ﹤0.01% 4623
2021
Q1
$0 Hold
1
– – ﹤0.01% 4318
2020
Q4
$0 Buy
+1
New +$8 ﹤0.01% 4115
2019
Q3
– Sell
-1
Closed – – 4058
2019
Q2
$0 Sell
1
-199
-100% -$1.32K ﹤0.01% 4006
2019
Q1
$2K Buy
200
+199
+19,900% +$1.55K ﹤0.01% 3419
2018
Q4
$0 Buy
+1
New +$4 ﹤0.01% 3887

Other funds holding MBOT

Fidelity Investments's MBOT Position: Q3 2026 in Review

Fidelity Investments increased its Microbot Medical (MBOT) stake by 793% in Q3 2026, buying an estimated $4.12K and bringing the position to 2,883 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #5154.

Fidelity Investments first reported a position in MBOT in Q4 2018 and has held it in 18 quarters since. 61 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Fidelity Investments held 2,883 shares of Microbot Medical worth $3.46K as of Q3 2026.
  • Fidelity Investments bought 2,560 Microbot Medical shares in Q3 2026, an estimated $4.12K.
  • Microbot Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5154 holding.
  • Fidelity Investments first reported a position in Microbot Medical in Q4 2018 and has held it in 18 quarters since.
  • 61 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.